Legal Representation
Attorney
Karen Lim
USPTO Deadlines
Next Deadline
2120 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-06)
Due Date
May 06, 2031
Grace Period Ends
November 06, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 6, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 6, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 28, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 28, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 22, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 6, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 4, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 4, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 4, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 18, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Sep 25, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Sep 25, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 25, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 10, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 10, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of respiratory, inflammatory, and immunological diseases and disorders; pharmaceutical preparations for the prevention and treatment of chronic obstructive pulmonary disease (COPD)
Classification
International Classes
005